Drug Development

Sep 10, 2018
By Pharmaceutical Technology Editors
The collaboration will explore the potential of Dyadic’s gene-expression platform to produce multiple biologic vaccines and drugs.
Sep 04, 2018
By Pharmaceutical Technology Editors
As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes.
Sep 02, 2018
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
Sep 02, 2018
Pharmaceutical Technology
Increasingly complex trial protocols have added to IMP manufacturing challenges.
Sep 02, 2018
Pharmaceutical Technology
Existing software tools cannot take into account the complexity of disease.
Sep 02, 2018
Pharmaceutical Technology
Sharing know-how can help resolve common bio/pharma technical challenges.
Sep 02, 2018
Pharmaceutical Technology
The European Commission’s proposed amendment on SPC waivers has sparked opposing views from drug originators and producers of generic drugs and biosimilars.
Sep 01, 2018
Pharmaceutical Technology
API-in-capsule approaches enable pharmaceutical companies to quickly assess new drug candidates with reduced API consumption and to increase speed to clinic.
Sep 01, 2018
Pharmaceutical Technology
Thixotropic gels, thermosoftened systems, and self-emulsifying systems have expanded the range of potential excipients for liquid-filled hard capsules (LFHC).
Sep 01, 2018
Pharmaceutical Technology
The authors review the potential of delivering aptamers to the skin, with evidence that therapeutically relevant levels can be reached in both the epidermis and dermis.
native1_300x100
lorem ipsum